Tag: Crossroads Neurovascular
Crossroads announces positive early clinical performance during Path BGC’s limited market...
Crossroads Neurovascular today announced successful early clinical experiences with its newly US Food and Drug Administration (FDA)-cleared Path balloon guide catheter (BGC) during the...
Crossroads Neurovascular secures US FDA clearance for “world’s first” 7Fr-compatible balloon...
Crossroads Neurovascular has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its “groundbreaking” PATH BGC device—a next-generation balloon...
